WHAT:
Rho, a full-service contract research organization (CRO), will provide valuable insight and important considerations for improving the inclusion and exclusion criteria for your next clinical trial through a free webinar. Adherence to inclusion and exclusion criteria is essential to the successful execution of a clinical trial. Deviations from these criteria must be avoided because they can jeopardize scientific integrity, regulatory acceptability, or the safety of subjects in the study.
In this webinar, Dr. Jack Modell, senior medical officer at Rho, will provide suggestions and advice on formulating inclusion and exclusion criteria to enhance the quality of subject selection, minimize protocol violations, and avoid protocol amendments.
WHO:
Jack Modell, MD, SMO, Rho
WHEN:
Tuesday, September 9, 2014
2:00 p.m. ET/ 11:00 a.m. PT
Duration: 60 minutes
Webinar Registration: http://www.fiercepharma.com/offer/rho_september2014?source=rho
DETAILS:
For media inquiries, please contact Kelly Maicon at Largemouth Communications, (919) 741-9784, kmaicon@largemouthpr.com.
ABOUT:
Rho, a privately-held, contract research organization (CRO) located in Chapel Hill, NC, provides a full range of clinical research services across the entire drug development process. For 30 years, Rho has been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. For more information, please visit www.rhoworld.com and follow us on Twitter.
Help employers find you! Check out all the jobs and post your resume.
